ATP1B2 and clear cell renal carcinoma: β1 and β2/AMOG mRNAs are decreased in renal, lung and hepatocellular carcinomas [64], and expression levels of the corresponding proteins are decreased in human clear cell renal cell carcinoma [51] and bladder carcinoma [65].